The Binet Staging System for Chronic Lymphocytic Leukemia (CLL) stages chronic lymphocytic leukemia, similar to Rai classification.

Doctors use staging to help them predict chronic lymphocytic leukemia's (CLL's) progression and develop an appropriate treatment plan. Two staging systems, the Rai system and the Binet System, have been used throughout the world.

Binet stage B: 3 or more areas of lymphoid tissue are enlarged, with no anemia or thrombocytopenia. Binet stage C: Anemia and/or thrombocytopenia are present. Any number of lymphoid tissue areas may be enlarged.

The Binet staging system. The Binet staging system for CLL has 3 stages: stage A – you have fewer than 3 groups of swollen (enlarged) lymph nodes; stage B – you have 3 or more groups of enlarged lymph nodes; stage C – you have a low number of red blood cells or platelets; The symptoms you might feel include:

2024年6月4日 · The Binet staging system is one of the two staging systems adopted in assessment of chronic lymphocytic leukemia (CLL). It classifies CLL according to the number of lymphoid tissues that are involved (i.e. the spleen and the lymph nodes of the neck, groin, and underarms), as well as the presence of anemia or thrombocytopenia.

2024年10月7日 · Chronic lymphocytic leukemia (CLL) staging helps determine how far the disease has progressed and when to start treatment. While most doctors in the United States use the Rai system, some use the Binet system or the …

We used to present survival statistics for the different CLL stage groups (stage A, B and C). But survival for CLL has changed. Doctors are using new targeted drugs that have improved the outlook for people with more advanced stages.

2019年1月7日 · The most common staging systems for CLL are the Rai and Binet systems. 4,5,14,15 The Rai system, more commonly used in the United States, differentiates among 3 risk groups based on blood and...

As defined above, treatment should be initiated in a patient with advanced (Binet C, Rai III–IV) or active, symptomatic disease. In this situation, patients need to be evaluated for their physical condition and comorbidity.

1981年7月1日 · This study allowed the authors to propose a new classification in three prognostic groups. Group C: anemia (Hb less than 10 g) and/or thrombopenia (platelets less than 100,000/mm3); about 15% of the patients; median of 2 years.